Concerns about lamotrigine
- PMID: 34022162
- DOI: 10.1016/S1474-4422(21)00132-0
Concerns about lamotrigine
Conflict of interest statement
NH and JWB declare no competing interests. RDT receives research support from Medtronic; fees as speaker or consultant from Theravance Biopharma and Arvelle Therapeutics; and lecture fees from Medtronic, UCB, and Novartis. MRK reports unrestricted educational grants and research grants for investigator-initiated studies from UCB and Eisai. JWS reports fees as speaker or consultant from Eisai, UCB, GW Pharmaceuticals, Arvelle, and Zogenix. RDT received research support from the Dutch Epilepsy Foundation, De Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie, and the Netherlands Organization for Health Research and Development. JWS is based at University College London Hospital and University College London Comprehensive Biomedical Research Centre, which receives a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. JWS receives support from the Dr Marvin Weil Epilepsy Research Fund, the Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie, and the UK Epilepsy Society.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
